Elevate Uranium Ltd Logo

Elevate Uranium Ltd

ELVUF

(0.8)
Stock Price

0,17 USD

-20.76% ROA

-61.77% ROE

-0.03x PER

Market Cap.

117.383.185,17 USD

0.62% DER

0% Yield

0% NPM

Elevate Uranium Ltd Stock Analysis

Elevate Uranium Ltd Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Elevate Uranium Ltd Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (1%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 Assets Growth

This company's revenue has shown remarkable growth over the past three years, making it an excellent choice for seeking a consistently prosperous investment.

3 ROE

The stock's ROE indicates a negative return (-40.9%) on shareholders' equity, suggesting poor financial performance.

4 ROA

The stock's ROA (-29.64%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

5 PBV

The stock's elevated P/BV ratio (6.91x) raises concerns about its overvaluation, making it an imprudent choice for investors seeking value.

6 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

7 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

8 Graham Number

The company's Graham number suggests that its stock price is overestimated, implying that it may not be a promising investment opportunity.

9 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

10 Dividend

The company's lack of dividends in the past three years may concern investors seeking regular income.

11 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (0), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

Elevate Uranium Ltd Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Elevate Uranium Ltd Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Elevate Uranium Ltd Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Elevate Uranium Ltd Revenue
Year Revenue Growth
1989 0
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 184 100%
2002 1.526.896 99.99%
2003 1.620.177 5.76%
2004 11.120 -14469.94%
2005 25.331 56.1%
2006 29.592 14.4%
2007 0 0%
2008 15.000 100%
2009 0 0%
2010 0 0%
2011 4.672 100%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 33.156 100%
2018 47.200 29.75%
2019 18 -262122.22%
2020 22 18.18%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Elevate Uranium Ltd Research and Development Expenses
Year Research and Development Expenses Growth
1989 0
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Elevate Uranium Ltd General and Administrative Expenses
Year General and Administrative Expenses Growth
1989 0
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 40.000 100%
2002 10.000 -300%
2003 566.165 98.23%
2004 140.506 -302.95%
2005 132.964 -5.67%
2006 166.366 20.08%
2007 1.736.917 90.42%
2008 1.934.019 10.19%
2009 4.204.394 54%
2010 5.244.602 19.83%
2011 2.834.213 -85.05%
2012 1.384.769 -104.67%
2013 1.328.157 -4.26%
2014 969.444 -37%
2015 1.097.406 11.66%
2016 1.313.260 16.44%
2017 1.149.643 -14.23%
2018 1.088.474 -5.62%
2019 1.123.138 3.09%
2020 1.319.163 14.86%
2021 1.369.090 3.65%
2022 2.592.459 47.19%
2023 858.727 -201.9%
2024 1.238 -69264.05%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Elevate Uranium Ltd EBITDA
Year EBITDA Growth
1989 -2.366.000
1990 -1.672.000 -41.51%
1991 -862.000 -93.97%
1992 -632.000 -36.39%
1993 -416.000 -51.92%
1994 -1.174.000 64.57%
1995 -1.054.000 -11.39%
1996 -390.342 -170.02%
1997 -76.516 -410.14%
1998 -102.466 25.33%
1999 -1.504.050 93.19%
2000 -296.868 -406.64%
2001 -852.553 65.18%
2002 -623.540 -36.73%
2003 -706.664 11.76%
2004 -1.874.076 62.29%
2005 -956.024 -96.03%
2006 1.357.073 170.45%
2007 -1.767.489 176.78%
2008 -4.691.516 62.33%
2009 -6.868.198 31.69%
2010 -9.617.385 28.59%
2011 -5.112.241 -88.12%
2012 -3.042.614 -68.02%
2013 -2.388.112 -27.41%
2014 -1.875.300 -27.35%
2015 -918.857 -104.09%
2016 -1.210.292 24.08%
2017 -1.452.837 16.69%
2018 -1.046.362 -38.85%
2019 -1.219.438 14.19%
2020 -1.822.704 33.1%
2021 -2.634.755 30.82%
2022 -5.689.189 53.69%
2023 -7.749.948 26.59%
2024 -8.933 -86656.39%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Elevate Uranium Ltd Gross Profit
Year Gross Profit Growth
1989 0
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 184 100%
2002 369.538 99.95%
2003 -836.774 144.16%
2004 11.120 7624.95%
2005 25.331 56.1%
2006 29.592 14.4%
2007 0 0%
2008 15.000 100%
2009 0 0%
2010 0 0%
2011 4.672 100%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 -6.818 100%
2017 -792.327 99.14%
2018 -587.877 -34.78%
2019 -4.299 -13577.92%
2020 -45.981 90.65%
2021 -54.294 15.31%
2022 -85.520 36.51%
2023 -117.680 27.33%
2024 -235.036 49.93%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Elevate Uranium Ltd Net Profit
Year Net Profit Growth
1989 -1.183.000
1990 -836.000 -41.51%
1991 -431.000 -93.97%
1992 -316.000 -36.39%
1993 -208.000 -51.92%
1994 -587.000 64.57%
1995 -527.000 -11.39%
1996 -195.171 -170.02%
1997 -38.258 -410.14%
1998 -102.556 62.7%
1999 -1.508.605 93.2%
2000 -299.028 -404.5%
2001 -908.441 67.08%
2002 -696.326 -30.46%
2003 -807.217 13.74%
2004 -2.035.669 60.35%
2005 -897.075 -126.92%
2006 -840.903 -6.68%
2007 -1.581.667 46.83%
2008 -5.064.838 68.77%
2009 -6.938.786 27.01%
2010 -9.651.377 28.11%
2011 -5.300.603 -82.08%
2012 -3.537.992 -49.82%
2013 -2.724.595 -29.85%
2014 -1.439.739 -89.24%
2015 -1.228.964 -17.15%
2016 -1.462.436 15.96%
2017 -1.686.169 13.27%
2018 -1.245.098 -35.42%
2019 -1.296.861 3.99%
2020 -1.658.605 21.81%
2021 -2.603.756 36.3%
2022 -5.729.835 54.56%
2023 -8.783.193 34.76%
2024 -8.859 -99044.29%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Elevate Uranium Ltd Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1989 0
1990 0 0%
1991 0 0%
1992 -6 100%
1993 -2 -400%
1994 -5 75%
1995 -32 87.5%
1996 -1 0%
1997 0 0%
1998 -1 0%
1999 -7 100%
2000 -1 0%
2001 -2 100%
2002 -1 -100%
2003 -1 0%
2004 -2 0%
2005 -1 0%
2006 0 0%
2007 -1 0%
2008 -2 100%
2009 -2 50%
2010 -2 0%
2011 -1 -100%
2012 -1 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Elevate Uranium Ltd Free Cashflow
Year Free Cashflow Growth
1989 0
1990 0 0%
1991 -269.000 100%
1992 -152.000 -76.97%
1993 -118.000 -28.81%
1994 -402.000 70.65%
1995 -332.000 -21.08%
1996 -49.993 -564.09%
1997 -6.641 -652.79%
1998 -26.576 75.01%
1999 -915 -2804.48%
2000 -40.350 97.73%
2001 -41.068 1.75%
2002 -310.348 86.77%
2003 -277.710 -11.75%
2004 -377.465 26.43%
2005 -475.280 20.58%
2006 -946.042 49.76%
2007 -1.072.072 11.76%
2008 -16.582 -6365.28%
2009 -92.637 82.1%
2010 -236.633 60.85%
2011 -66.239 -257.24%
2012 0 0%
2013 -2.584.310 100%
2014 -1.102.297 -134.45%
2015 -680.960 -61.87%
2016 -589.824 -15.45%
2017 -1.527.552 61.39%
2018 -867.120 -76.16%
2019 -1.164.029 25.51%
2020 -1.754.338 33.65%
2021 -2.395.949 26.78%
2022 -4.490.529 46.64%
2023 -5.901.651 23.91%
2024 -2.278 -259085.38%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Elevate Uranium Ltd Operating Cashflow
Year Operating Cashflow Growth
1989 0
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 -2.561.821 100%
2014 -1.100.257 -132.84%
2015 -675.801 -62.81%
2016 -589.824 -14.58%
2017 -1.527.552 61.39%
2018 -867.120 -76.16%
2019 -1.152.160 24.74%
2020 -1.452.084 20.65%
2021 -2.334.669 37.8%
2022 -4.377.533 46.67%
2023 -5.827.134 24.88%
2024 -2.245 -259576.2%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Elevate Uranium Ltd Capital Expenditure
Year Capital Expenditure Growth
1989 0
1990 0 0%
1991 269.000 100%
1992 152.000 -76.97%
1993 118.000 -28.81%
1994 402.000 70.65%
1995 332.000 -21.08%
1996 49.993 -564.09%
1997 6.641 -652.79%
1998 26.576 75.01%
1999 915 -2804.48%
2000 40.350 97.73%
2001 41.068 1.75%
2002 310.348 86.77%
2003 277.710 -11.75%
2004 377.465 26.43%
2005 475.280 20.58%
2006 946.042 49.76%
2007 1.072.072 11.76%
2008 16.582 -6365.28%
2009 92.637 82.1%
2010 236.633 60.85%
2011 66.239 -257.24%
2012 0 0%
2013 22.489 100%
2014 2.040 -1002.4%
2015 5.159 60.46%
2016 0 0%
2017 0 0%
2018 0 0%
2019 11.869 100%
2020 302.254 96.07%
2021 61.280 -393.23%
2022 112.996 45.77%
2023 74.517 -51.64%
2024 33 -225709.09%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Elevate Uranium Ltd Equity
Year Equity Growth
1989 394.000
1990 470.000 16.17%
1991 95.000 -394.74%
1992 398.000 76.13%
1993 190.000 -109.47%
1994 344.000 44.77%
1995 -79.000 535.44%
1996 268.094 129.47%
1997 229.836 -16.65%
1998 938.435 75.51%
1999 949.852 1.2%
2000 1.620.884 41.4%
2001 1.989.686 18.54%
2002 2.219.302 10.35%
2003 4.386.890 49.41%
2004 2.025.560 -116.58%
2005 1.482.928 -36.59%
2006 2.604.993 43.07%
2007 3.427.499 24%
2008 2.054.385 -66.84%
2009 9.459.302 78.28%
2010 2.436.099 -288.3%
2011 1.345.855 -81.01%
2012 1.086.407 -23.88%
2013 -1.638.147 166.32%
2014 -1.880.129 12.87%
2015 -1.810.701 -3.83%
2016 -1.992.527 9.13%
2017 -1.504.292 -32.46%
2018 -1.207.265 -24.6%
2019 503.750 339.66%
2020 3.924.259 87.16%
2021 9.526.815 58.81%
2022 18.492.893 48.48%
2023 11.518.396 -60.55%
2024 17.607.664 34.58%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Elevate Uranium Ltd Assets
Year Assets Growth
1989 426.000
1990 484.000 11.98%
1991 127.000 -281.1%
1992 427.000 70.26%
1993 204.000 -109.31%
1994 397.000 48.61%
1995 49.000 -710.2%
1996 284.256 82.76%
1997 234.836 -21.04%
1998 952.828 75.35%
1999 1.704.543 44.1%
2000 2.066.003 17.5%
2001 3.323.543 37.84%
2002 3.162.189 -5.1%
2003 6.166.920 48.72%
2004 2.180.999 -182.76%
2005 1.607.801 -35.65%
2006 2.738.998 41.3%
2007 3.714.943 26.27%
2008 2.713.882 -36.89%
2009 10.851.859 74.99%
2010 2.946.204 -268.33%
2011 3.670.115 19.72%
2012 3.211.424 -14.28%
2013 593.072 -441.49%
2014 163.769 -262.14%
2015 465.238 64.8%
2016 595.188 21.83%
2017 528.095 -12.7%
2018 873.250 39.53%
2019 799.064 -9.28%
2020 4.359.257 81.67%
2021 9.956.353 56.22%
2022 19.331.487 48.5%
2023 12.539.305 -54.17%
2024 18.253.604 31.31%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Elevate Uranium Ltd Liabilities
Year Liabilities Growth
1989 32.000
1990 14.000 -128.57%
1991 32.000 56.25%
1992 29.000 -10.34%
1993 14.000 -107.14%
1994 53.000 73.58%
1995 128.000 58.59%
1996 16.162 -691.98%
1997 5.000 -223.24%
1998 14.393 65.26%
1999 754.691 98.09%
2000 445.119 -69.55%
2001 1.333.857 66.63%
2002 942.887 -41.47%
2003 1.780.030 47.03%
2004 155.439 -1045.16%
2005 124.873 -24.48%
2006 134.005 6.81%
2007 287.444 53.38%
2008 659.497 56.41%
2009 1.392.557 52.64%
2010 510.105 -172.99%
2011 2.324.260 78.05%
2012 2.125.017 -9.38%
2013 2.231.219 4.76%
2014 2.043.898 -9.16%
2015 2.275.939 10.2%
2016 2.587.715 12.05%
2017 2.032.387 -27.32%
2018 2.080.515 2.31%
2019 295.314 -604.51%
2020 434.998 32.11%
2021 429.538 -1.27%
2022 838.594 48.78%
2023 1.020.909 17.86%
2024 645.940 -58.05%

Elevate Uranium Ltd Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-13.52
Price to Earning Ratio
-0.03x
Price To Sales Ratio
0x
POCF Ratio
-0.04
PFCF Ratio
-44.72
Price to Book Ratio
0.01
EV to Sales
0
EV Over EBITDA
-29.62
EV to Operating CashFlow
-39.4
EV to FreeCashFlow
-38.74
Earnings Yield
-35.52
FreeCashFlow Yield
-0.02
Market Cap
0,12 Bil.
Enterprise Value
0,10 Bil.
Graham Number
138.21
Graham NetNet
54.22

Income Statement Metrics

Net Income per Share
-13.52
Income Quality
0.68
ROE
-0.21
Return On Assets
-0.76
Return On Capital Employed
-0.8
Net Income per EBT
1
EBT Per Ebit
1.07
Ebit per Revenue
0
Effective Tax Rate
0.04

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0
Operating Profit Margin
0
Pretax Profit Margin
0
Net Profit Margin
0

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-9.21
Free CashFlow per Share
-9.36
Capex to Operating CashFlow
-0.02
Capex to Revenue
0
Capex to Depreciation
0.92
Return on Invested Capital
-0.2
Return on Tangible Assets
-0.21
Days Sales Outstanding
0
Days Payables Outstanding
416.58
Days of Inventory on Hand
-0.49
Receivables Turnover
0
Payables Turnover
0.88
Inventory Turnover
-737.54
Capex per Share
0.16

Balance Sheet

Cash per Share
56,13
Book Value per Share
62,80
Tangible Book Value per Share
62.8
Shareholders Equity per Share
62.8
Interest Debt per Share
0.42
Debt to Equity
0.01
Debt to Assets
0.01
Net Debt to EBITDA
4.57
Current Ratio
26.44
Tangible Asset Value
0,02 Bil.
Net Current Asset Value
0,02 Bil.
Invested Capital
17652852
Working Capital
0,02 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
-72.02
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Elevate Uranium Ltd Dividends
Year Dividends Growth

Elevate Uranium Ltd Profile

About Elevate Uranium Ltd

Elevate Uranium Ltd engages in the exploration and evaluation of uranium deposits. The company's principal projects include the Koppies, Hirabeb, Marenica, and Namib IV in Namibia. It also holds 100% interests in the Angela, Thatcher Soak, Oobagooma, and Minerva project areas, as well as the Bigrlyi, Malawiri, Walbiri, and Areva joint ventures in Australia. The company was formerly known as Marenica Energy Limited and changed its name to Elevate Uranium Ltd in May 2021. Elevate Uranium Ltd was incorporated in 1978 and is headquartered in West Perth, Australia.

CEO
Mr. Murray Philip Hill B.Sc.,
Employee
0
Address
5 Ord Street
West Perth, 6005

Elevate Uranium Ltd Executives & BODs

Elevate Uranium Ltd Executives & BODs
# Name Age
1 Mr. Murray Philip Hill B.Sc., Fausimm
MD, Chief Executive Officer & Director
70
2 Mr. Shane McBride B.Bus (Acct), FCIS, FCPA, FGIA, MAICD
Chief Financial Officer & Company Secretary
70
3 Ms. Jessica Bezuidenhout
General Manager of Namibia
70
4 Mr. Berti Roesener
Consulting Exploration Manager of Namibia
70
5 Mr. David John Princep B.Sc., P.Geo., B.Sc, FAusIMM(CP)
Consulting Geologist
70

Elevate Uranium Ltd Competitors